Adrafinil, a synthetic Nootropic compound, is a prodrug for Modafinil. This means that supplementation of the peptide leads to increased concentrations of modafinil.
Studies have shown it increases alertness and wakefulness because it is a stimulant. However, it does not cause hyperactivity, instead it fights sleepiness.
Studies are currently being conducted to see whether there is a correlation between this peptide and improved memory. Further research is needed to confirm this effect.
Adrafinil works vicariously through modafinil. Further research is needed to determine the exact mechanisms of modafinil. Preliminary evidence suggests histaminergic signaling may play a vital role.
Safety information on this peptide is lacking because modafinil is often used instead for narcolepsy and excessive daytime sleepiness. It is metabolized into modafinil in the liver and there is no available evidence regarding liver safety. This is a needed area of research for the peptide. Adrafinil and modafinil are banned by the World Anti-Doping Agency (WADA) as a nonspecific stimulant compound.